Observational studyInternational urology and nephrology2026
SGLT2 inhibitors and their role in reducing adiposopathy and inflammation in diabetes and non-diabetes CKD patients.
Ana Checa-Ros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.